Systemic lupus erythematosus myocarditis after COVID-19 vaccination.
Reumatol Clin (Engl Ed)
; 19(2): 114-116, 2023 Feb.
Article
in English
| MEDLINE | ID: covidwho-2221313
ABSTRACT
INTRODUCTION:
Cases of acute myocarditis have been after administration of the BNT162b2 and Ad26.COV2.S vaccine.OBJECTIVE:
Describe another possible mechanism of myocarditis after COVID-19 vaccination. CASE PRESENTATION We describe the clinical case of a 72-year-old female with pleuritic chest pain one week after the third of the BNT162b2 mRNA vaccine. Serological tests for cardiotropic pathogens were negative, and autoimmunity screening was positive with anti-nuclear antibody (ANA) in 1160 dilution, Anti-double-stranded DNA (anti-dsDNA), and anti-histone antibodies. 18F-fluoro-deoxy-glucose (FDG) positron emission tomography/computed tomography (PET/CT) showed a focal myocardial and pericardial inflammatory process in the cardiac apex. RESULTS ANDDISCUSSION:
Systemic lupus erythematosus (SLE) diagnosis was made with myocardial affection. As far as we know, this is the first report of a case of lupus myocarditis after the COVID-19 vaccine.CONCLUSION:
Given the pathogenic rationales, the association between SLE and myocarditis should be considered.Keywords
Full text:
Available
Collection:
International databases
Database:
MEDLINE
Main subject:
COVID-19 Vaccines
/
COVID-19
/
Lupus Erythematosus, Systemic
/
Myocarditis
Type of study:
Case report
/
Diagnostic study
/
Observational study
/
Prognostic study
Topics:
Vaccines
Limits:
Aged
/
Female
/
Humans
Language:
English
Journal:
Reumatol Clin (Engl Ed)
Year:
2023
Document Type:
Article
Similar
MEDLINE
...
LILACS
LIS